Sign up
Quantellect · Congress · Trade Detail
CELGCelgene Corporation (CELG) [ST] F ILING S TaTUS : New S UBHoLDING o F : IRa account #2
RepublicanHouse

Van Taylor sold Celgene Corporation (CELG) [ST] F ILING S TaTUS : New S UBHoLDING o F : IRa account #2 (CELG)

Van Taylor (R-TX), a U.S. Representative, has disclosed 7 trades in Celgene Corporation (CELG) [ST] F ILING S TaTUS : New S UBHoLDING o F : IRa account #2 (CELG) since 2019, all sales, worth an estimated $56K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a sale: Van Taylor sold $1,001 - $15,000 of Celgene Corporation (CELG) [ST] F ILING S TaTUS : New S UBHoLDING o F : IRa account #2 (CELG) on February 5, 2019. Since that trade, CELG is up +0.00% against the S&P 500 up +197.82%, an outperformance of -197.82%.

Across these filings, Van Taylor has been a net seller of CELG. The most recent disclosed CELG transaction shown was dated February 8, 2019. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

CELG trades
7
Disclosed Vol
$56K
Buys
0
0%
Sells
7
100%
Buy / Sell
0.00
ratio
First → Last
2019

Van Taylor's CELG trades vs the price

CELG is up +0.00% since Van Taylor sold on February 5, 2019, versus +197.82% for the S&P 500.

Performance since this trade

Price change since trade
+0.00%
S&P 500 change since trade
+197.82%
Outperformance vs S&P 500
-197.82%

All Van Taylor CELG trades

TradedTypeSizeReturnEst. profit
February 8, 2019SELL$1,001 - $15,000N/A
February 5, 2019SELL$1,001 - $15,000N/A
February 4, 2019SELL$1,001 - $15,000N/A
January 31, 2019SELL$1,001 - $15,000N/A
January 30, 2019SELL$1,001 - $15,000N/A
January 10, 2019SELL$1,001 - $15,000N/A
January 8, 2019SELL$1,001 - $15,000N/A

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Van Taylor & CELG trading FAQ

Is it legal for Van Taylor to trade Celgene Corporation (CELG) [ST] F ILING S TaTUS : New S UBHoLDING o F : IRa account #2 (CELG) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Celgene Corporation (CELG) [ST] F ILING S TaTUS : New S UBHoLDING o F : IRa account #2 (CELG), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Van Taylor sell CELG?

Van Taylor disclosed a sale of $1,001 - $15,000 of Celgene Corporation (CELG) [ST] F ILING S TaTUS : New S UBHoLDING o F : IRa account #2 (CELG) on February 5, 2019, according to public STOCK Act filings.

How has CELG performed since Van Taylor's trade?

Since Van Taylor sold CELG on February 5, 2019, the stock is up +0.00%, versus +197.82% for the S&P 500 over the same period, an outperformance of -197.82%.

How many times has Van Taylor traded CELG?

Van Taylor has disclosed 7 CELG trades since 2019. Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional CELG trades?

Quantellect tracks every disclosed congressional trade in Celgene Corporation (CELG) [ST] F ILING S TaTUS : New S UBHoLDING o F : IRa account #2 (CELG) on the Celgene Corporation (CELG) [ST] F ILING S TaTUS : New S UBHoLDING o F : IRa account #2 congressional trading page, which aggregates filings across all members of Congress.

Van Taylor's CELG tradesAll congressional filings for Celgene Corporation (CELG) [ST] F ILING S TaTUS : New S UBHoLDING o F : IRa account #2Van Taylor's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.